Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study-Reference-Cited by-同舟云学术

Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study

Published:2018-02 Issue:2 Volume:19 Page:169-180
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Copson Ellen R,Maishman Tom C,Tapper Will J,Cutress Ramsey I,Greville-Heygate Stephanie,Altman Douglas G,Eccles Bryony,Gerty Sue,Durcan Lorraine T,Jones Louise,Evans D Gareth,Thompson Alastair M,Pharoah Paul,Easton Douglas F,Dunning Alison M,Hanby Andrew,Lakhani Sunil,Eeles Ros,Gilbert Fiona J,Hamed Hisham,Hodgson Shirley,Simmonds Peter,Stanton Louise,Eccles Diana M

Publisher

Elsevier BV

Subject

Oncology

Reference31 articles.

1. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases;Anglian Breast Cancer Study Group;Br J Cancer,2000

2. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years;Malone;Cancer Res,2006

3. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression;Anders;J Clin Oncol,2008

4. Platinum chemotherapy for BRCA1-related breast cancer: do we need more evidence?;Turner;Breast Cancer Res,2012

5. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations;Lakhani;J Natl Cancer Inst,1998

Cited by 286 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased risk of contralateral breast cancer for BRCA1/2 wild-type, high-risk Korean breast cancer patients: a retrospective cohort study;Breast Cancer Research;2024-01-22

2. Pregnancy is not contraindicated in pathogenic BRCA carriers;Medicom Conference Report SABCS 2023;2024-01-11

3. Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status;BMC Medicine;2024-01-09

4. Pregnancy After Breast Cancer in Young BRCA Carriers;JAMA;2024-01-02

5. Feasibility and acceptability of offering breast cancer risk assessment to general population women aged 30–39 years: a mixed-methods study protocol;BMJ Open;2024-01